Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Prostate (All Stages^), 2016-2020

All Races (includes Hispanic), Male, All Ages

Sorted by Name
State
 sort alphabetically by name descending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Recent Trend
Recent 5-Year Trend in Incidence Rates
(95% Confidence Interval)
 sort by trend descending
US (SEER+NPCR) 1 110.5 (110.2, 110.7) N/A 212,734 rising rising trend 2.5 (1.0, 4.1)
Alabama 6 120.3 (118.5, 122.1) 16 (12, 19) 3,693 stable stable trend 0.1 (-2.3, 1.9)
Alaska 6 99.0 (94.3, 103.9) 40 (34, 47) 395 stable stable trend 7.5 (-2.2, 13.9)
Arizona 6 76.4 (75.2, 77.5) 49 (49, 49) 3,503 stable stable trend -0.2 (-2.7, 5.0)
Arkansas 6 111.3 (109.2, 113.5) 30 (23, 33) 2,108 stable stable trend 2.1 (-1.0, 7.6)
California 7 95.4 (94.8, 96.0) 46 (43, 47) 20,666 stable stable trend 2.0 (-0.6, 5.7)
Colorado 6 98.5 (96.9, 100.1) 41 (37, 45) 3,175 rising rising trend 5.3 (3.7, 6.7)
Connecticut 7 122.7 (120.6, 124.8) 13 (9, 17) 2,844 rising rising trend 5.3 (2.6, 9.1)
Delaware 6 125.0 (121.1, 128.9) 9 (7, 17) 834 stable stable trend 1.0 (-1.4, 3.8)
District of Columbia 6 130.5 (124.7, 136.4) 7 (2, 13) 407 stable stable trend 3.2 (-3.5, 11.5)
Florida 6 97.0 (96.3, 97.7) 44 (40, 45) 14,762 falling falling trend -2.5 (-3.2, -1.3)
Georgia 7 134.7 (133.3, 136.1) 4 (3, 6) 7,711 rising rising trend 4.4 (1.4, 8.1)
Hawaii 7 101.1 (98.2, 104.1) 37 (34, 44) 950 rising rising trend 5.8 (3.5, 8.9)
Idaho 7 118.8 (115.9, 121.8) 18 (12, 24) 1,283 rising rising trend 5.9 (2.1, 10.4)
Illinois 7 115.1 (114.0, 116.2) 22 (19, 27) 8,714 stable stable trend 1.4 (-0.6, 4.1)
Iowa 7 120.4 (118.2, 122.6) 15 (11, 19) 2,432 rising rising trend 4.3 (3.0, 6.4)
Kansas 6 116.3 (114.0, 118.6) 20 (16, 27) 2,037 rising rising trend 4.0 (0.6, 9.1)
Kentucky 7 108.3 (106.6, 110.1) 33 (30, 34) 3,010 stable stable trend 2.4 (-1.9, 5.4)
Louisiana 7 138.1 (136.1, 140.1) 2 (2, 4) 3,817 rising rising trend 3.8 (1.1, 7.4)
Maine 6 98.3 (95.5, 101.1) 42 (35, 47) 1,025 rising rising trend 3.4 (0.8, 7.0)
Maryland 6 135.7 (133.9, 137.4) 3 (2, 5) 4,853 rising rising trend 4.7 (2.4, 7.7)
Massachusetts 7 113.2 (111.8, 114.7) 27 (21, 30) 4,864 rising rising trend 4.6 (1.6, 8.5)
Michigan 6 112.1 (110.9, 113.3) 29 (24, 31) 7,353 stable stable trend 3.5 (0.0, 8.6)
Minnesota 6 113.1 (111.5, 114.7) 28 (21, 30) 3,953 stable stable trend 1.8 (-0.8, 6.0)
Mississippi 6 131.4 (128.9, 133.8) 5 (4, 8) 2,342 rising rising trend 3.0 (0.9, 5.7)
Missouri 6 96.0 (94.6, 97.4) 45 (41, 47) 3,733 stable stable trend 1.7 (-0.9, 4.8)
Montana 6 131.2 (127.5, 135.0) 6 (3, 9) 1,023 stable stable trend 4.9 (-0.4, 10.5)
Nebraska 6 124.8 (121.9, 127.8) 10 (8, 15) 1,447 rising rising trend 6.1 (3.1, 9.9)
New Hampshire 6 114.2 (111.1, 117.3) 24 (17, 31) 1,123 rising rising trend 4.0 (1.2, 8.2)
New Jersey 7 143.3 (141.9, 144.8) 1 (1, 1) 7,783 stable stable trend 3.6 (-2.1, 7.6)
New Mexico 7 85.6 (83.3, 87.8) 48 (48, 48) 1,164 stable stable trend 0.8 (-1.0, 4.0)
New York 7 130.3 (129.4, 131.2) 8 (5, 9) 15,456 rising rising trend 2.6 (1.0, 4.5)
North Carolina 6 123.9 (122.6, 125.2) 11 (8, 14) 7,846 rising rising trend 3.0 (0.9, 5.6)
North Dakota 6 122.0 (117.4, 126.8) 14 (8, 22) 556 stable stable trend 2.1 (-1.2, 7.7)
Ohio 6 114.1 (113.0, 115.2) 25 (21, 28) 8,558 rising rising trend 4.1 (1.3, 7.7)
Oklahoma 6 100.5 (98.7, 102.4) 38 (34, 43) 2,342 stable stable trend 3.7 (-0.6, 9.4)
Oregon 6 94.4 (92.8, 96.1) 47 (43, 47) 2,621 stable stable trend 1.5 (-0.8, 5.4)
Pennsylvania 6 108.9 (107.9, 109.9) 32 (30, 33) 9,412 stable stable trend 2.8 (-1.3, 7.3)
Puerto Rico 6 141.2 (138.8, 143.5) N/A 2,873 stable stable trend 2.5 (-0.5, 5.5)
Rhode Island 6 114.2 (110.5, 117.9) 23 (16, 33) 783 rising rising trend 6.6 (2.1, 12.1)
South Carolina 6 109.8 (108.2, 111.5) 31 (28, 33) 3,659 falling falling trend -3.5 (-4.2, -2.8)
South Dakota 6 123.2 (119.0, 127.5) 12 (8, 19) 697 stable stable trend 3.0 (-1.4, 8.0)
Tennessee 6 116.1 (114.6, 117.6) 21 (17, 26) 4,868 stable stable trend 2.5 (-0.1, 5.7)
Texas 7 103.4 (102.6, 104.1) 34 (34, 37) 14,706 rising rising trend 4.5 (2.0, 8.0)
Utah 7 117.4 (114.8, 120.0) 19 (14, 26) 1,652 stable stable trend 1.1 (-1.5, 6.2)
Vermont 6 101.9 (97.7, 106.3) 36 (33, 45) 474 rising rising trend 7.5 (2.9, 13.7)
Virginia 6 102.1 (100.8, 103.3) 35 (34, 40) 5,216 stable stable trend 0.5 (-1.4, 3.9)
Washington 5 100.3 (98.9, 101.6) 39 (35, 42) 4,539 stable stable trend 1.8 (-0.5, 5.3)
West Virginia 6 97.7 (95.3, 100.2) 43 (37, 47) 1,295 rising rising trend 4.2 (0.5, 8.5)
Wisconsin 6 118.9 (117.3, 120.5) 17 (14, 21) 4,604 rising rising trend 4.2 (2.4, 6.7)
Wyoming 6 113.7 (108.9, 118.6) 26 (14, 33) 449 stable stable trend 2.9 (0.0, 8.9)
Indiana 6
data not available
N/A
data not available
data not available
data not available
Nevada 6
data not available
N/A
data not available
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 04/14/2024 8:02 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
‡ Incidence data come from different sources. Due to different years of data availability, most of the trends are AAPCs based on APCs but some are APCs calculated in SEER*Stat. Please refer to the source for each area for additional information.

Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2022 submission).
7 Source: SEER November 2022 submission.
8 Source: Incidence data provided by the SEER Program. AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Population counts for denominators are based on Census populations as modifed by NCI. The US Population Data File is used with SEER November 2022 data.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top